![Alex Yang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 74 M $ as of 31/05/2026
Alex Yang is currently Chairman & Chief Executive Officer at Polaryx Therapeutics, Inc. since 2023, Chairman & Chief Executive Officer at Epygenix Therapeutics, Inc., and Chief Executive Officer at Mstone Partners Hong Kong Ltd. Formerly, Mr. Yang was Managing Partner at Kim & Chang.
Education includes undergraduate studies at State University of New York at Binghamton and graduate studies at New York University School of Law.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 27/05/2026 | 22,744,796 ( 48.04% ) | 74 M $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| POLARYX THERAPEUTICS, INC. | Chief Executive Officer | 01/03/2023 |
Epygenix Therapeutics, Inc.
 Epygenix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurological disorders | Chief Executive Officer | - |
Mstone Partners Hong Kong Ltd. | Chief Executive Officer | - |
| Companies | Position | End |
|---|---|---|
Kim & Chang
 Kim & Chang Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 6 |
|---|---|
Kim & Chang
Kim & Chang Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
State University of New York at Binghamton
 State University of New York at Binghamton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University School of Law
 New York University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mstone Partners Hong Kong Ltd. | |
Epygenix Therapeutics, Inc.
Epygenix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurological disorders | Health Technology |
Polaryx Therapeutics, Inc.
 Polaryx Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that engages in discovery, development and commercialization of novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions
Choose MarketScreener 
